Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2582084
Reference Type
Journal Article
Title
In vitro Interactions with Repeated Grapefruit Juice Administration - to Peel or not to Peel?
Author(s)
Brill, S; Zimmermann, C; Berger, K; Drewe, J; Gutmann, H
Year
2009
Is Peer Reviewed?
1
Journal
Planta Medica
ISSN:
0032-0943
EISSN:
1439-0221
Volume
75
Issue
4
Page Numbers
332-335
PMID
19148864
DOI
10.1055/s-0028-1112210
Web of Science Id
WOS:000264895100009
Abstract
Interactions of acutely administered grapefruit juice (GFJ) with cytochrome P450 isoform 3A4 (CYP3A4) and P-glycoprotein (Pgp) function are well established. In this study, we investigated in vitro the effect of repeated administration of GFJ and its major constituents (the flavonoid naringin, its aglycone naringenin and the furanocoumarin bergamottin) on mRNA expression of MDR1 and CYP3A4 in LS180 cells. Since the bergamottin content is higher in the peel than in the fruit, we compared GFJ containing peel (GFJP+) with juice without any peel extract (GFJP-). GFJP-(1%) showed no significant effect on MDR1 and CYP3A4 mRNA expression, whereas 1% GFJP+ increased expression of MDR1 3.7-fold (P < 0.01) and CYP3A4 2.3-fold (P < 0.05). Of the tested constituents, only 10 PM bergamottin and 200 mu M naringenin induced MDR1 mRNA levels 2.9- and 4.0-fold, respectively (P < 0.01 for both), and CYP3A4 mRNA levels 3.2- and 15.6-fold (P < 0.01 for both), respectively. Western blot analysis and rhodamine 123 uptake experiments partly confirmed these findings on the protein and the functional level. In summary, GFJ containing no peel extract may have a lower potential for interactions with CYP3A4 or P-glycoprotein.
Keywords
grapefruit juice; bergamottin; CYP3A4; P-glycoprotein; Citrus x paradisi Macfad; naringin/naringenin
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity